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INTRODUCTION  
Localized lymphoid hyperplasia is also called 
“pseudolymphoma”, and this has been found in various 
organs, including the skin, orbit, thyroid, breast, lung, 
gastrointestinal tract, liver and pancreas (1-6). It is 
characterized by the presence of hyperplastic lymphoid 
follicles with populations of polymorphic and polyclonal 
cells, and these cell populations are composed of small 
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mature lymphocytes, mature plasma cells, macrophages and 
stromal fibrosis.
Localized lymphoid hyperplasia of the pancreas is 
extremely rare and it has rarely been described in the 
literature (1-3). The imaging findings of pancreatic 
localized lymphoid hyperplasia are not well known. 
Thus, it is still indistinguishable from other pancreatic 
neoplasms both clinically or radiographically. To the best 
of our knowledge, only three cases of pancreatic localized 
lymphoid hyperplasia have been reported in the English 
medical literature (1-3). Moreover, these reports included 
solitary localized lymphoid hyperplasia of the pancreas and 
the imaging findings were briefly described as a hypoechoic 
lesion on ultrasonography (US) with a normal arterial 
distribution on angiography (2). We report here on a case of 
double localized lymphoid hyperplasia of the pancreas with 
an emphasis on the imaging findings of ultrasonography, 
computed tomography (CT) and magnetic resonance (MR) 
imaging. Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 511









Fig. 1. Localized lymphoid hyperplasia of pancreas in 70-year-old man.
A. Color Doppler ultrasonographic image shows hypoechoic mass (asterisk) in uncinate process of pancreas without discernible vascularity within 
mass. A = aorta, S = superior mesenteric vein. B, C. Contrast-enhanced 3-minute delayed phase CT images reveal two localized masses in uncinate 
process (about 2 x 1.8 cm for mass size) and tail (about 1.8 x 1.5 cm for mass size) of pancreas without peripancreatic stranding (arrows in B 
and arrowheads in C), and these masses show slightly more enhancement, as compared to that of pancreatic parenchyma. D. T2-weighted MR 
image shows localized hyperintense mass without peripancreatic stranding in uncinate process of pancreas (arrow). E, F. Gadolinium-enhanced 
dynamic T1-weighted images show slightly hypointense mass (arrow in E) on arterial phase image (E) in uncinate process of pancreas, and 
mass appears as slightly hyperintense on portal phase image (F). G. Photograph of resected specimen shows well circumscribed yellowish mass 
(arrowheads) in uncinate process of pancreas. H. Photomicrograph shows lymphoid follicles (asterisk) surrounded by dense collagenous tissue. 
Lymphoid follicles are composed of enlarged germinal centers surrounded by rims of small lymphocytes (Hematoxylin & Eosin staining, x 100). 
On immunohistochemical staining, neither lymphocytic infiltrate with monoclonal cell proliferation nor immunoreactivity for IgG4 was found in 
lesions.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 512
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CASE REPORT
A 70-year-old man was admitted to our hospital for 
the evaluation of a pancreatic mass that was incidentally 
detected during a screening abdominal sonographic 
examination. He was asymptomatic and he did not have 
any specific medical history. He had a habit of drinking 
one or two cups of alcohol daily for several decades. The 
laboratory tests at the time of admission revealed that the 
CA19-9, CEA, alpha-fetoprotein, amylase and lipase levels 
were within the normal limits. The ultrasonographic images 
showed a hypoechoic mass in the uncinate process of the 
pancreas, and this was not accompanied by dilatation of the 
main pancreatic duct. There was no discernible vascularity 
within the mass on the color Doppler image (Fig. 1A). We 
then performed contrast-enhanced multidetector-row CT. 
The contrast-enhanced dynamic CT images revealed two 
round masses with one each in the uncinate process (about 
2 x 1.8 cm for the mass size) and tail (about 1.8 x 1.5 cm 
for the mass size) of the pancreas; these isodense masses 
on the unenhanced CT images were slightly hypodense, 
slightly hyperdense and slightly hyperdense, respectively 
as compared to the pancreas parenchyma on the contrast-
enhanced arterial, portal, and delayed-phase CT images that 
were obtained at 30 seconds, 75 seconds and 180 seconds, 
respectively, after the injection of contrast agent (Fig. 1B, 
C). There were no enlarged lymph nodes in the abdomen. 
MR imaging was performed to further evaluate these 
pancreatic masses. The MR images demonstrated that the 
two masses were hypointense and hyperintense on the T1- 
and T2-weighted images, respectively (Fig. 1D). Although 
subtle enhancement of the two masses was detected, 
these lesions were shown to be of slight hypointensity as 
compared to the intensity of the pancreas parenchyma on 
the gadolinium-enhanced arterial phase T1-weighted image 
obtained at 25 seconds after the injection of contrast agent 
(Fig. 1E). Meanwhile, the mass lesions were more enhanced 
than the pancreas parenchyma on the portal and delayed-
phase T1-weighted MR images (Fig. 1F) obtained at 60 
seconds and 180 seconds, respectively, after the injection 
of contrast agent.
Several imaging findings of these tumors, such as 
the delayed enhancement, the double lesions and the 
normal caliber of the main pancreatic duct, resulted in 
the preoperative tentative diagnosis of neuroendocrine 
tumor or lymphoma. Under this impression, endoscopic US-
guided biopsy was performed, but this failed. Finally, total 
pancreaticoduodenectomy was performed for these masses 
because the malignant potential of these masses could not 
be ruled out. 
The gross surgical specimen showed two well 
circumscribed yellowish masses in the uncinate process 
and tail of the pancreas (Fig. 1G). Microscopic examination 
revealed lymphoid follicles with enlarged germinal 
centers and dense, rich collagenous fibrous tissue 
admixed with a lymphoplasma cell infiltration (Fig. 1H). 
The immunohistochemical stains demonstrated that the 
follicular lymphocytic infiltrate of a polyclonal origin 
was composed of germinal centers with cells expressing 
B-cell characteristics and these germinal centers were 
surrounded by rims of cells expressing T-cell characteristics.
No immunoreactivity for IgG4 was noted. These histologic 
features resulted in the diagnosis of localized lymphoid 
hyperplasia of the pancreas. He had an uneventful 
postoperative course and he has been alive for 18 months 
after surgery.
DISCUSSION
Localized lymphoid hyperplasia can manifest as a focal 
mass-like lesion that is well-defined from the surrounding 
tissue (2). Localized lymphoid hyperplasia has been 
described as a hypoechoic mass on ultrasonograms and 
as a well demarcated mass on CT images (2, 4, 5). In our 
case, the localized lymphoid hyperplasia was visualized in 
the form of a discernible mass with delayed enhancement 
on the imaging studies. Given that the border between the 
localized lymphoid hyperplasia and the surrounding pancreas 
parenchyma was sharply demarcated on the pathologic 
specimen, it seems to be natural that the localized lymphoid 
hyperplasia was seen as a circumscribed round mass on all 
imaging studies. In the previous reports (4, 5) on lymphoid 
hyperplasia of the liver, the lesions appeared to be hypo- 
and hyperintense nodules on the T1- and T2-weighted 
images, respectively, which is similar to our case. In regard 
to contrast enhancement, reactive lymphoid hyperplasia 
of the liver showed a variety of dynamic enhancement 
patterns from arterial hypervascularity followed by washout 
to arterial hypovascularity with slight enhancement. In our 
case, the localized lymphoid hyperplasia of the pancreas 
showed arterial hypovascularity with delayed enhancement. 
We think that the enhancement pattern in our case was 
attributed to the presence of a rich fibrous matrix in the 
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Localized Lymphoid Hyperplasia of Pancreas
The dilatation of the pancreatic duct is one of valuable 
additional findings for characterizing any pancreatic 
tumor. The presence of dilatation of the pancreatic duct 
that is induced by a pancreatic mass usually increases the 
possibility of malignant tumor. According to the previous 
reports (2, 3), pancreatic localized lymphoid hyperplasia 
was accompanied with the dilatation of the pancreatic duct 
or common bile duct, and this was interpreted to be the 
result of the mass effect of localized lymphoid hyperplasia 
on the pancreatic duct or the common bile duct. In our 
case, the diameter of the pancreatic duct showed a normal 
caliber. This may reflect that pancreatic localized lymphoid 
hyperplasia is unrelated to the pancreatic duct for its origin 
and the tumor has a benign histology. In addition, the one 
mass that was located in the uncinate process seemed to 
have no mass effect or a minimal mass effect on the main 
pancreatic duct. 
Localized lymphoid hyperplasia is not considered to have 
any malignant potential (4, 5). Given that pseudolymphoma 
may denote a low-grade mucosa-associated lymphoid 
tissue (MALT) lymphoma, and malignant transformation 
of pseudolymphoma has been sporadically reported in the 
literature (5, 7), the term “localized lymphoid hyperplasia” 
seems to more accurately reflect the pathologic findings of 
our case than the term “pseudolymphoma”. 
The differential diagnosis of localized lymphoid 
hyperplasia of the pancreas includes neuroendocrine 
tumor, autoimmune pancreatitis, lymphoma and solid 
pseudopapillary tumor. Although neuroendocrine tumors are 
usually thought to be seen as hypervascular masses on the 
arterial phase images, the degree, uniformity and temporal 
change of the enhancement on the dynamic contrast-
enhanced images can be highly variable (8). Especially, 
more attention needs to be paid to distinguish between a 
delayed-enhancing, nonfunctioning neuroendocrine tumor 
and localized lymphoid hyperplasia. Given the imaging 
findings of localized lymphoid hyperplasia of the pancreas 
in this case, the presence of cystic or necrotic change in 
the mass may favor a diagnosis of neuroendocrine tumor. 
The localized form of autoimmune pancreatitis may present 
with a focal mass-like lesion and it share several imaging 
features with our case, such as delayed enhancement, a 
nondilated pancreatic duct and tumor multiplicity (9). 
However, the localized form of autoimmune pancreatitis 
was reported to be often accompanied by wall thickening 
and enhancement of the common bile duct and upstream 
dilatation, and particularly in the cases whose pancreatic 
head was involved (9), which may be diagnostic points 
to differentiate it from localized lymphoid hyperplasia. 
Pancreatic lymphoma sometimes manifests as a localized, 
well circumscribed mass in the pancreas, and this is not 
accompanied by dilatation of the pancreatic duct (10). In 
contrast with pancreatic localized lymphoid hyperplasia, 
pancreatic lymphoma appears as a heterogeneous mass with 
low to intermediate signal intensity on the T2-weighted 
images and as a hypovascular mass on the contrast-
enhanced images. Finally, solid pseudopapillary tumor (SPT) 
needs to be included in the list of the differential diagnoses 
because small (less than 3 cm) SPTs can appear as well-
defined solid lesions with delayed enhancement (11). 
In summary, we present here an interesting case of 
double pancreatic localized lymphoid hyperplasia with 
the US, CT and MR imaging findings. Although it is rare, 
localized lymphoid hyperplasia of the pancreas should be 
included in the differential diagnosis of pancreatic tumor, 
and especially when the imaging studies show a localized, 
delayed enhancing mass of the pancreas without any 
dilatation of the pancreatic duct.
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